The focal adhesion kinase Pyk2 links Ca2+ signalling to Src family kinase activation and protein tyrosine phosphorylation in thrombin-stimulated platelets
In blood platelets, stimulation of G protein-coupled receptors (GPCRs) by thrombin triggers the activation of Src family kinases (SFKs), resulting in the tyrosine-phosphorylation of multiple substrates, but the mechanism underlying this process is still poorly understood. In the present study, we sh...
| Main Authors: | Canobbio, I., Cipolla, L., Guidetti, G., Manganaro, D., Visconte, C., Kim, S., Okigaki, M., Falasca, Marco, Kunapuli, S., Torti, M. |
|---|---|
| Format: | Journal Article |
| Published: |
Portland Press Ltd
2015
|
| Online Access: | http://hdl.handle.net/20.500.11937/14640 |
Similar Items
The role of the focal adhesion kinase Pyk2 in platelet activation
by: Cipolla, L., et al.
Published: (2011)
by: Cipolla, L., et al.
Published: (2011)
The role of the focal adhesion kinase PYK2 in platelet activation
by: Canobbio, I., et al.
Published: (2011)
by: Canobbio, I., et al.
Published: (2011)
Impaired thrombin-induced platelet activation and thrombus formation in mice lacking the Ca2+-dependent tyrosine kinase Pyk2
by: Canobbio, I., et al.
Published: (2013)
by: Canobbio, I., et al.
Published: (2013)
The proline-rich tyrosine kinase Pyk2 regulates platelet integrin aIIbß3 outside-in signaling
by: Cipolla, L., et al.
Published: (2013)
by: Cipolla, L., et al.
Published: (2013)
Activation of phosphatidylinositol 3-kinase ß by the platelet collagen receptors integrin a2ß1 and GPVI: The role of Pyk2 and c-Cbl
by: Manganaro, D., et al.
Published: (2015)
by: Manganaro, D., et al.
Published: (2015)
The tyrosine kinase Pyk2 mediates the cross-talk between platelet integrins alpha 2 beta 1 and alpha IIb beta 3
by: Guidetti, G., et al.
Published: (2011)
by: Guidetti, G., et al.
Published: (2011)
The tyrosine kinase PYK2 mediates the cross-talk between platelet integrins alpha 2 beta 1 and alpha iib beta 3
by: Guidetti, G., et al.
Published: (2011)
by: Guidetti, G., et al.
Published: (2011)
Role of Focal Adhesion Tyrosine Kinases in GPVI-Dependent Platelet Activation and Reactive Oxygen Species Formation
by: Carrim, N., et al.
Published: (2014)
by: Carrim, N., et al.
Published: (2014)
Role and regulation of phosphatidylinositol 3-kinase ß in platelet integrin α2ß1 signaling
by: Consonni, A., et al.
Published: (2012)
by: Consonni, A., et al.
Published: (2012)
Examining the importance of survivin phosphorylation at Threonine 5 through its relationship with the kinase, TBK1, and the substrate, c-Src
by: Lishak, Jamie
Published: (2019)
by: Lishak, Jamie
Published: (2019)
Phosphorylation And Regulation
Of Human Choline Kinase Beta
By Protein Kinase A
by: Chang , Ching Ching
Published: (2015)
by: Chang , Ching Ching
Published: (2015)
Phosphorylation And Regulation
Of Human Choline Kinase Beta
By Protein Kinase A
by: Chang , Ching Ching
Published: (2015)
by: Chang , Ching Ching
Published: (2015)
Src family tyrosine kinase Lyn mediates VWF GPIb-IX induced platelet activation via the cGMP signaling pathway
by: Yin, H., et al.
Published: (2008)
by: Yin, H., et al.
Published: (2008)
Analysis of phosphorylation sites of protein kinases in Cryptosporidium
by: Barudin, Mohd Aiman, et al.
Published: (2018)
by: Barudin, Mohd Aiman, et al.
Published: (2018)
Self-assembling tyrosine kinase inhibitors for localised targeted delivery
by: Al-Ameedee, Mohammed
Published: (2017)
by: Al-Ameedee, Mohammed
Published: (2017)
Effects of protein kinase a phosphorylation on
the biochemical properties and subcellular
location of human choline kinase beta
by: Cun, See Too Wei
Published: (2016)
by: Cun, See Too Wei
Published: (2016)
An apoferritin-based drug delivery system for the tyrosine kinase inhibitor gefitinib
by: Kuruppu, Anchala I., et al.
Published: (2015)
by: Kuruppu, Anchala I., et al.
Published: (2015)
EGFR-directed tyrosine kinase inhibitors for non-small cell lung cancer
by: Fatin Nur Elyana Mohd Sidek,, et al.
Published: (2025)
by: Fatin Nur Elyana Mohd Sidek,, et al.
Published: (2025)
Adaptive therapy to circumvent drug resistance to tyrosine kinase inhibitors in cancer: is it clinically relevant?
by: Hamdi, Amir Imran Faisal, et al.
Published: (2022)
by: Hamdi, Amir Imran Faisal, et al.
Published: (2022)
Defining the Anti-Cancer Activity of Tricarbonyl Rhenium Complexes: Induction of G2/M Cell Cycle Arrest and Blockade of Aurora-A Kinase Phosphorylation
by: Simpson, Peter, et al.
Published: (2017)
by: Simpson, Peter, et al.
Published: (2017)
Phosphorylation of PRH/HHEX by Protein Kinase CK2 Regulates Cell Proliferation and Cell Migration in Diverse Cell Types
by: Jayaraman, Padma-Sheela, et al.
Published: (2018)
by: Jayaraman, Padma-Sheela, et al.
Published: (2018)
Benzalhydantoin derivative-based inhibitors of eight receptor tyrosine kinases: synthesis, in-vitro, and in-silico study
by: Muhammad Naufal,, et al.
Published: (2025)
by: Muhammad Naufal,, et al.
Published: (2025)
Case series of small cell lung cancer transformation post tyrosine kinase inhibitor failure
by: Chai, C.S., et al.
Published: (2017)
by: Chai, C.S., et al.
Published: (2017)
Determination of gene expression of tyrosine kinase receptors (HER family) in FFPE tissue of colorectal adenocarcinoma
by: Othman @ Jaffar, Rosfayati, et al.
Published: (2015)
by: Othman @ Jaffar, Rosfayati, et al.
Published: (2015)
An investigation into the effects of the epidermal growth factor receptor tyrosine kinase inhibitor "Gefitinib" on human breast cancer
by: Gutteridge, Eleanor
Published: (2010)
by: Gutteridge, Eleanor
Published: (2010)
Effects of 4 multitargeted receptor tyrosine kinase inhibitors on regional hemodynamics in conscious, freely moving rats
by: Carter, Joanne J., et al.
Published: (2016)
by: Carter, Joanne J., et al.
Published: (2016)
Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules
by: Yu, Yu, et al.
Published: (2015)
by: Yu, Yu, et al.
Published: (2015)
Linifanib – a multi-targeted receptor tyrosine kinase inhibitor and a low molecular weight gelator
by: Marlow, Maria, et al.
Published: (2015)
by: Marlow, Maria, et al.
Published: (2015)
Spectroscopic and molecular modeling studies on the interaction of tyrosine kinase inhibitors with human serum albumin / Md. Zahirul Kabir
by: Md. Zahirul , Kabir
Published: (2018)
by: Md. Zahirul , Kabir
Published: (2018)
Resistance mechanisms causing first-line epidermal growth factor receptor-tyrosine kinase inhibitor treatment failure
by: Chai, C.S., et al.
Published: (2017)
by: Chai, C.S., et al.
Published: (2017)
Investigating the mechanisms of activation and action of phosphoinositide 3-kinase C2 alpha in pancreatic beta cells
by: Mazza, S., et al.
Published: (2013)
by: Mazza, S., et al.
Published: (2013)
Regulation and cellular functions of class II phosphoinositide 3-kinases
by: Falasca, Marco, et al.
Published: (2012)
by: Falasca, Marco, et al.
Published: (2012)
Genetic and epigenetic regulation of phosphoinositide 3-kinase isoforms
by: Fyffe, C., et al.
Published: (2013)
by: Fyffe, C., et al.
Published: (2013)
Phosphoinositide 3-kinase pathway inhibitors: pharmacology, metabolism & drug development
by: Falasca, Marco
Published: (2011)
by: Falasca, Marco
Published: (2011)
New insight into the intracellular roles of class II phosphoinositide 3-kinases
by: Maffucci, T., et al.
Published: (2014)
by: Maffucci, T., et al.
Published: (2014)
Case Series of Small Cell Lung Cancer Transformation
as Resistance Mechanism to Epidermal Growth Factor
Receptor-Tyrosine Kinase Inhibitor
by: Liam, C, et al.
Published: (2017)
by: Liam, C, et al.
Published: (2017)
Akt/protein kinase B in skeletal muscle physiology and pathology
by: Wu, M., et al.
Published: (2011)
by: Wu, M., et al.
Published: (2011)
Effects of receptor tyrosine kinase inhibitors on VEGF165a- and VEGF165b-stimulated gene transcription in HEK-293 cells expressing human VEGFR2
by: Carter, Joanne J., et al.
Published: (2015)
by: Carter, Joanne J., et al.
Published: (2015)
Real-time analysis of the binding of fluorescent VEGF₁₆₅a to VEGFR2 in living cells: Effect of receptor tyrosine kinase inhibitors and fate of internalized agonist-receptor complexes
by: Kilpatrick, Laura E., et al.
Published: (2017)
by: Kilpatrick, Laura E., et al.
Published: (2017)
A phase 2 trial of decreasing tyrosine kinase inhibitor dose in chronic myeloid leukaemia patients with stable major molecular response: data from the British DESTINY study
by: Clark, Richard E., et al.
Published: (2017)
by: Clark, Richard E., et al.
Published: (2017)
Similar Items
-
The role of the focal adhesion kinase Pyk2 in platelet activation
by: Cipolla, L., et al.
Published: (2011) -
The role of the focal adhesion kinase PYK2 in platelet activation
by: Canobbio, I., et al.
Published: (2011) -
Impaired thrombin-induced platelet activation and thrombus formation in mice lacking the Ca2+-dependent tyrosine kinase Pyk2
by: Canobbio, I., et al.
Published: (2013) -
The proline-rich tyrosine kinase Pyk2 regulates platelet integrin aIIbß3 outside-in signaling
by: Cipolla, L., et al.
Published: (2013) -
Activation of phosphatidylinositol 3-kinase ß by the platelet collagen receptors integrin a2ß1 and GPVI: The role of Pyk2 and c-Cbl
by: Manganaro, D., et al.
Published: (2015)